Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
for
Metastatic Malignant Solid Neoplasm,
Location: Boston MA, Mineola NY, New York NY, Bethesda MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687110
Phase1, Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: St. John's, Sydney, Halifax, Moncton, Saint John,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Riverhead NY, Hartford CT, Holyoke MA,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for
Malignant Female Reproductive System Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06126276
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
for
Alcohol Use Disorder
Location: Bethesda MD
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sex: All
Age: 21 - 65
Code: NCT06269627
Recruiting
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions
for
Genetic Eye Disease
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)
Sex: All
Age: 0 - 70+
Code: NCT02077894
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
for
HER2-positive Advanced Solid Tumor
Location: Boston MA, Shirley NY, Lake Success NY, New York NY,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05150691
Phase1, Phase2, Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase2, Recruiting
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.
for
Atrial Fibrillation
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 21+
Code: NCT06308094
Recruiting
Study in Patients With Breast Cancer Leptomeningeal Metastasis
for
Leptomeningeal Metastasis of Breast Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 0+
Code: NCT06638294
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Halifax, Boston MA, Quebec, Egg Harbor NJ, Montreal,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors